Insider Trading Alert - PACW, DYAX, YELP, SYK And NUAN Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Friday, Dec. 6, 2013, 134 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $99.28 to $13,815,000.00.

Highlighted Stocks Traded by Insiders:

PacWest Bancorp (PACW) - FREE Research Report

Carlson Craig A who is Director at PacWest Bancorp bought 300 shares at $41.70 on Dec. 6, 2013. Following this transaction, the Director owned 1,750 shares meaning that the stake was reduced by 20.69% with the 300-share transaction.

The shares most recently traded at $42.07, up $0.37, or 0.88% since the insider transaction. Historical insider transactions for PacWest Bancorp go as follows:

  • 4-Week # shares bought: 2,000
  • 4-Week # shares sold: 10,000
  • 12-Week # shares bought: 2,000
  • 12-Week # shares sold: 10,000
  • 24-Week # shares bought: 2,000
  • 24-Week # shares sold: 10,000

The average volume for PacWest Bancorp has been 583,600 shares per day over the past 30 days. PacWest Bancorp has a market cap of $1.8 billion and is part of the financial sector and banking industry. Shares are up 67.5% year-to-date as of the close of trading on Friday.

PacWest Bancorp operates as the bank holding company for Pacific Western Bank that provides commercial banking products and services to small to medium sized businesses, and the owners and employees of those businesses primarily in Southern California. The stock currently has a dividend yield of 2.41%. The company has a P/E ratio of 26.4. Currently there are 5 analysts that rate PacWest Bancorp a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on PACW - FREE

TheStreet Quant Ratings rates PacWest Bancorp as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, compelling growth in net income, expanding profit margins and good cash flow from operations. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full PacWest Bancorp Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Dyax Corporation (DYAX) - FREE Research Report

Kempner Thomas L who is Director at Dyax Corporation sold 400,000 shares at $8.37 on Dec. 6, 2013. Following this transaction, the Director owned 1.0 million shares meaning that the stake was reduced by 28.39% with the 400,000-share transaction.

The shares most recently traded at $8.14, down $0.23, or 2.81% since the insider transaction.

The average volume for Dyax Corporation has been 1.5 million shares per day over the past 30 days. Dyax Corporation has a market cap of $999.9 million and is part of the health care sector and drugs industry. Shares are up 137.36% year-to-date as of the close of trading on Friday.

Dyax Corp., a biopharmaceutical company, engages in the identification, development, and commercialization of treatments for plasma kallikrein-mediated (PKM) angioedemas. It offers KALBITOR for the treatment of acute attacks of hereditary angioedema (HAE). Currently there are 4 analysts that rate Dyax Corporation a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on DYAX - FREE

TheStreet Quant Ratings rates Dyax Corporation as a sell. Among the areas we feel are negative, one of the most important has been unimpressive growth in net income over time. Get the full Dyax Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Yelp (YELP) - FREE Research Report

Fenton Peter H who is Director at Yelp sold 20,000 shares at $61.64 on Dec. 6, 2013. Following this transaction, the Director owned 102,378 shares meaning that the stake was reduced by 16.34% with the 20,000-share transaction.

The shares most recently traded at $63.14, up $1.50, or 2.37% since the insider transaction. Historical insider transactions for Yelp go as follows:

  • 4-Week # shares sold: 339,656
  • 12-Week # shares sold: 339,656
  • 24-Week # shares sold: 734,156

The average volume for Yelp has been 3.6 million shares per day over the past 30 days. Yelp has a market cap of $3.6 billion and is part of the technology sector and internet industry. Shares are up 232.2% year-to-date as of the close of trading on Friday.

Yelp, Inc. operates Yelp.com, an online urban city guide that helps people find places to eat, shop, drink, relax, and play based on the informed opinions of a community of locals in the know. Currently there are 10 analysts that rate Yelp a buy, no analysts rate it a sell, and 10 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on YELP - FREE

TheStreet Quant Ratings rates Yelp as a sell. The company's weaknesses can be seen in multiple areas, such as its unimpressive growth in net income and feeble growth in its earnings per share. Get the full Yelp Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Stryker Corporation (SYK) - FREE Research Report

Stryker Ronda E who is Director at Stryker Corporation sold 21,000 shares at $73.77 on Dec. 6, 2013. Following this transaction, the Director owned 11.4 million shares meaning that the stake was reduced by 0.18% with the 21,000-share transaction.

The shares most recently traded at $74.45, up $0.68, or 0.92% since the insider transaction. Historical insider transactions for Stryker Corporation go as follows:

  • 12-Week # shares sold: 2,000
  • 24-Week # shares sold: 2,000

The average volume for Stryker Corporation has been 1.3 million shares per day over the past 30 days. Stryker Corporation has a market cap of $27.7 billion and is part of the health care sector and health services industry. Shares are up 35.94% year-to-date as of the close of trading on Friday.

Stryker Corporation, a medical technology company, provides reconstructive, medical and surgical, and neurotechnology and spine products for doctors, hospitals, and other healthcare facilities. The stock currently has a dividend yield of 1.67%. The company has a P/E ratio of 31.4. Currently there are 14 analysts that rate Stryker Corporation a buy, 1 analyst rates it a sell, and 10 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SYK - FREE

TheStreet Quant Ratings rates Stryker Corporation as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations, expanding profit margins and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Stryker Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Nuance Communications (NUAN) - FREE Research Report

Bowden Adam Bruce who is Executive VP Corporate Strateg at Nuance Communications sold 10,494 shares at $13.54 on Dec. 6, 2013. Following this transaction, the Executive VP Corporate Strateg owned 266,066 shares meaning that the stake was reduced by 3.79% with the 10,494-share transaction.

The shares most recently traded at $14.18, up $0.64, or 4.5% since the insider transaction. Historical insider transactions for Nuance Communications go as follows:

  • 4-Week # shares sold: 8,000
  • 12-Week # shares sold: 463,000
  • 24-Week # shares sold: 546,630

The average volume for Nuance Communications has been 6.5 million shares per day over the past 30 days. Nuance Communications has a market cap of $4.5 billion and is part of the technology sector and computer software & services industry. Shares are down 36.2% year-to-date as of the close of trading on Friday.

Nuance Communications, Inc. provides voice and language solutions for businesses and consumers worldwide. Currently there are 2 analysts that rate Nuance Communications a buy, no analysts rate it a sell, and 10 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on NUAN - FREE

TheStreet Quant Ratings rates Nuance Communications as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and weak operating cash flow. Get the full Nuance Communications Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Data for this article provided by Zacks Investment Research
null

If you liked this article you might like

Community Banks Feeling Share-Price Pressure as Overexposure to CRE Loans Grows

Community Banks Feeling Share-Price Pressure as Overexposure to CRE Loans Grows

Don't Forget, the Barrage of Bad News for Wells Fargo Will Soon Become a Distant Memory

Don't Forget, the Barrage of Bad News for Wells Fargo Will Soon Become a Distant Memory

Wall Street Week Ahead: Is Chaos the New Normal?

Wall Street Week Ahead: Is Chaos the New Normal?

Community Banks' Increasing Real Estate Loans Exposure Problematic

Community Banks' Increasing Real Estate Loans Exposure Problematic

Ignore Bullish Hype on Rate Hikes -- Book Profits on Community Banks Now

Ignore Bullish Hype on Rate Hikes -- Book Profits on Community Banks Now